the egyptian society of cardiology board of ... - Cardioegypt.com
the egyptian society of cardiology board of ... - Cardioegypt.com
the egyptian society of cardiology board of ... - Cardioegypt.com
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Ayman Sadek, et al<br />
with mean age <strong>of</strong> 51.2±9.21 years. There was no<br />
significance difference between <strong>the</strong> three subgroups<br />
as regard age and sex distribution (p>0.05). These<br />
data are presented in Table (2).<br />
I- Description and <strong>com</strong>parison between <strong>the</strong><br />
study groups:<br />
1- Age and sex:<br />
Fig. (1) demonstrates age and gender distribution<br />
among <strong>the</strong> study.<br />
14<br />
12<br />
10<br />
8<br />
6<br />
4<br />
2<br />
0<br />
Males<br />
Females<br />
Group I Group II Group III<br />
Figure 1: Sex distribution in <strong>the</strong> three studied groups.<br />
2- Risk factors:<br />
Every patient was asked about risk factors <strong>of</strong><br />
a<strong>the</strong>rosclerosis and special habits <strong>of</strong> medical importance<br />
and it was found that 25% <strong>of</strong> group I,<br />
41.7% among group II and 32% among group III<br />
were smokers or ex-smokers, whereas, positive<br />
family history <strong>of</strong> IHD, CVA or peripheral vascular<br />
disease was found to be 8.3% among group I, 5.9%<br />
among group II and 23% among group III. Past<br />
history <strong>of</strong> HTN, DM or past history <strong>of</strong> dyslipidemia<br />
by lipid pr<strong>of</strong>ile and regular intake <strong>of</strong> hypolipidemic<br />
drugs were considered among selection criteria for<br />
metabolic syndrome. These data and distribution<br />
<strong>of</strong> o<strong>the</strong>r metabolic risk factors are shown in Table<br />
(2).<br />
3- Clinical examination and laboratory investigations:<br />
All patients underwent clinical examination,<br />
where blood pressure, waist circumference in cm,<br />
height in meters, body weight in kg were measured<br />
and body mass index was calculated and LAB<br />
evaluation <strong>of</strong> blood sugar and lipid pr<strong>of</strong>ile. It was<br />
found that systolic and diastolic blood pressures<br />
were higher in group III, TG, female W.C, BMI<br />
and FBS were highest in group II while HDL-C<br />
was lowest in group III. Data are shown in Table<br />
(3).<br />
43<br />
Table 2: Distribution <strong>of</strong> risk factors within <strong>the</strong> study groups.<br />
Smoking<br />
FH<br />
HTN<br />
DM<br />
Dyslipidemia<br />
(+ve<br />
history)<br />
No (%)<br />
TG<br />
(increased)<br />
No (%)<br />
HDL-C<br />
(decreased)<br />
W.C<br />
(increased)<br />
Table 3: Quantitative analysis <strong>of</strong> risk factors <strong>of</strong> <strong>the</strong> study<br />
groups by using mean and SD.<br />
Systolic BP<br />
Diastolic BP<br />
DUR <strong>of</strong> HTN<br />
FBS<br />
DUR <strong>of</strong> DM<br />
TG<br />
HDL-C:<br />
Males<br />
Females<br />
W.C.:<br />
Males<br />
Females<br />
BMI<br />
Group I<br />
(no=12)<br />
3 (25%)<br />
1 (8.3%)<br />
10 (83.3%)<br />
5 (41/7%)<br />
1 (8.3%)<br />
8 (66.7%)<br />
10 (83.3%) 15 (88.2%) 21 (100%) 3.38<br />
5 (41.7%)<br />
Group I<br />
(no=12)<br />
Mean (SD)<br />
135.83+<br />
(20.54)<br />
83.33+<br />
(11.93)<br />
2.83+<br />
(3.49)<br />
147.5+<br />
(78.47)<br />
2.67+<br />
(4.47)<br />
170.42+<br />
(23.69)<br />
37.26+<br />
(5.6)<br />
44.2+<br />
(7.9)<br />
106+<br />
(9.41)<br />
95.21+<br />
(8.31)<br />
28.68+<br />
(3.12)<br />
Group II<br />
(no=17)<br />
7 (41.7%)<br />
1 (5.9%)<br />
15 (88.2%)<br />
8 (47.1%)<br />
4 (23.5%)<br />
17 (100%)<br />
FH = Family history.<br />
TG = Triglycerides.<br />
HDL-C = High density<br />
lipoprotein-cholesterol.<br />
BP = Blood pressure.<br />
FBS = Fang blood pressure.<br />
TG = Triglycerides.<br />
HDL-C = High density<br />
lipoprotein cholesterol.<br />
Group III<br />
(no=21)<br />
6 (32.0%)<br />
5 (23.8%)<br />
21 (100%)<br />
8 (38.0%)<br />
9 (42.9%)<br />
21 (100%) 13.77 0.001<br />
15 (88.2%) 21 (100%) 18.28 0.000<br />
Group II<br />
(no=17)<br />
Mean (SD)<br />
127.29+<br />
(22.45)<br />
81.17+<br />
(9.44)<br />
3.35+<br />
(5.80)<br />
152.47+<br />
(64.59)<br />
3.41+<br />
(4.03)<br />
191.35+<br />
(13.49)<br />
35.1<br />
(6.91)<br />
45.3+<br />
(8.3)<br />
108.36+<br />
(12.31)<br />
99.21+<br />
(7.81)<br />
31.83+<br />
(3.65)<br />
F<br />
1.04<br />
2.92<br />
3.38<br />
0.31<br />
4.77<br />
0.59<br />
0.23<br />
0.19<br />
0.86<br />
0.09<br />
0.19<br />
W.C = Waist circumference.<br />
HTN = Hypertension.<br />
DM = Diabetes mellitus.<br />
Group III<br />
(no=21)<br />
Mean (SD)<br />
150.0+<br />
(9.49)<br />
94.52+<br />
(9.73)<br />
6.47+<br />
(5.42)<br />
149.8+<br />
(48.83)<br />
2.33+<br />
(3.75)<br />
181.71+<br />
(16.55)<br />
33.3+<br />
(6.72)<br />
41.7+<br />
(8.31)<br />
112.38+<br />
(11.45)<br />
98.61+<br />
(10.81)<br />
31.31+<br />
(4.17)<br />
W.C = Waist circumference.<br />
BMI = Body mass index.<br />
DUR = Duration.<br />
p